Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 52
- Uncategorized
Ananda Lists on US OTCQB Market, Argent Bio Signs Data Sharing Deal With AusCann, & IMC Under New Threat of NASDAQ Delisting
Ananda Pharma [stock_market_widget type=”chart” template=”line” assets=”ANANF” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Just days after welcoming the former Chief Operating Officer of GW and Jazz Pharmaceuticals to its ranks Ananda has announced its entrance onto the US OTCQB Exchange, opening up its stock to US investors.
- Adult-Use
France’s Top Medical Body Reaffirms Hardline Stance on Cannabis
In a press release published on 9 April, the Académie de Médecine (French Academy of Medicine) reiterated its prohibitionist stance on cannabis, citing a select range of public health concerns and international studies to support its position while consciously omitting the harm caused by prohibition.
- Uncategorized
How a Colorado Operator Stumbled Onto ‘Blueprint for Laundering Marijuana’
The CEO Mammoth Farms stumbled onto ‘the blueprint for how to launder marijuana’ in and out of the state’s regulated industry, he told MJBizDaily.
- CBD Market
UK’s FSA Softens Stance on 0% THC in CBD Products, as MHRA Draws Clear Line on CBD Medical Claims
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the Food Standards Agency (FSA) have both issued regulatory updates on CBD this week.
- Uncategorized
Public Money May Have Helped Defeat Florida’s Cannabis Legalization Ballot
Florida Governor Ron Desantis and his wife are coming under increasing scrutiny over their apparent use of millions in public settlement funds to bankroll a critical anti-cannabis legalization campaign.
- Uncategorized
Cannabis Rescheduling ‘Delayed Not Dead’, Despite DEA’s Apathy
The US Cannabis Roundtable (USCR), one of the most influential advocacy groups in the country, is ‘still optimistic about the President acting on cannabis reform’.
- Press releases
Mamedica to Become ‘Official Licence Holder and Distributor’ of Cannabis Giant Cookies in the UK
Mamedica has today announced an exclusive partnership with Cookies to offer its premium pharmaceutical products to patients across the UK.
- Uncategorized
Israel’s 165% Tariffs on Canadian Cannabis Imports Approved by Ministry of Health
Israel has seemingly followed in the footsteps of its US ally this week after announcing plans to impose 165% tariffs on cannabis imports from Canada.
- Adult-Use
German Cannabis Law Remains Uncertain, Malta Imposes Controversial Changes, Dutch Cannabis Experiment Progresses, & More from Czech Republic
From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.
- Uncategorized
‘Liberation Day’ Tariffs Already Impacting Cannabis Businesses, and Consumers
Licensed cannabis operators and ancillary companies are bracing for rising business costs, lost customers and vendor backlash in the wake of President Donald Trump’s erratic blanket tariffs that have rattled the global economy and stoked fears of a recession and accelerated inflation in the United States.
- Uncategorized
FDA Hammered by Lawmakers on Capitol Hill for Allowing Intoxicating Hemp Industry to Flourish
The US Food and Drug Administration (FDA) was dragged through the mud by lawmakers yesterday, who said its ‘bureaucratic red tape, inefficiencies, and weak oversight’ was responsible for the flood of intoxicating hemp substances across the country.
- Markets & Stocks
Argent Bio’s Stock Flies on German Approval, Jazz Hit by Tariff Barrage, & Kanabo Cautions ‘Financial Uncertainty’
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma has managed to overcome the wider chaos on the stock markets this week, seeing its stock jump over 40% in the wake of two major announcements.
